找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Optimizing Breast Cancer Management; William J. Gradishar Book 2018 Springer International Publishing AG 2018 Anti - HER2 Therapy.Bisphosp

[復(fù)制鏈接]
查看: 16404|回復(fù): 48
樓主
發(fā)表于 2025-3-21 17:26:16 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Optimizing Breast Cancer Management
編輯William J. Gradishar
視頻videohttp://file.papertrans.cn/704/703339/703339.mp4
概述Focuses on recent data that influence surgical techniques, radiation therapy techniques, and medical therapeutics.Discusses new insights into genetic and lifestyle risks for breast cancer and risk red
叢書名稱Cancer Treatment and Research
圖書封面Titlebook: Optimizing Breast Cancer Management;  William J. Gradishar Book 2018 Springer International Publishing AG 2018 Anti - HER2 Therapy.Bisphosp
描述This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. Inclosing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance.
出版日期Book 2018
關(guān)鍵詞Anti - HER2 Therapy; Bisphosphonates; Endocrine Resistance; Non-invasive Breast Cancer; Sentinel Lymph N
版次1
doihttps://doi.org/10.1007/978-3-319-70197-4
isbn_softcover978-3-319-88901-6
isbn_ebook978-3-319-70197-4Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightSpringer International Publishing AG 2018
The information of publication is updating

書目名稱Optimizing Breast Cancer Management影響因子(影響力)




書目名稱Optimizing Breast Cancer Management影響因子(影響力)學(xué)科排名




書目名稱Optimizing Breast Cancer Management網(wǎng)絡(luò)公開度




書目名稱Optimizing Breast Cancer Management網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Optimizing Breast Cancer Management被引頻次




書目名稱Optimizing Breast Cancer Management被引頻次學(xué)科排名




書目名稱Optimizing Breast Cancer Management年度引用




書目名稱Optimizing Breast Cancer Management年度引用學(xué)科排名




書目名稱Optimizing Breast Cancer Management讀者反饋




書目名稱Optimizing Breast Cancer Management讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

1票 100.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:12:50 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:36:27 | 只看該作者
bewirkte O. eine Konzentration und engagierte Mitarbeit der →Ch?re der Stadt im Hinblick auf seine gro?en Aufführungen klassischer Oratorien. Da er die von den Nationalsozialisten angeordnete ?Gleichschaltung“ der Hochschule nicht entsprechend deren Vorstellungen betrieb, wurde er 1939 entlassen.
地板
發(fā)表于 2025-3-22 05:47:54 | 只看該作者
5#
發(fā)表于 2025-3-22 12:45:55 | 只看該作者
6#
發(fā)表于 2025-3-22 12:52:33 | 只看該作者
Sarah M. Friedewald eines Nebeneinander und partiellen Miteinander bei gleichzeitigem Gegeneinander zu erreichen. Es soll also keine geschichtliche Darstellung der deutschen Teilung, des Auseinanderlebens in Deutschland gegeben werden. Vielmehr soll der Vergleich einzelner politisch-staatlicher und wirtschaftlich-sozi
7#
發(fā)表于 2025-3-22 19:55:48 | 只看該作者
8#
發(fā)表于 2025-3-23 00:04:02 | 只看該作者
9#
發(fā)表于 2025-3-23 02:03:06 | 只看該作者
Readdressing the Role of Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer,cal trials have shown conflicting results, and others are ongoing. In this chapter, we discuss the results of these studies through the present day and summarize their conclusions and their implications for clinical management.
10#
發(fā)表于 2025-3-23 07:19:56 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 01:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄浦区| 靖宇县| 洮南市| 庆阳市| 康马县| 马龙县| 桃江县| 宜丰县| 鄂伦春自治旗| 沅陵县| 本溪市| 定边县| 乐亭县| 鹤庆县| 同德县| 富蕴县| 杭州市| 耿马| 陆河县| 马公市| 海城市| 仪征市| 长沙市| 六盘水市| 湛江市| 军事| 抚顺市| 浑源县| 蒙城县| 枝江市| 宁安市| 万载县| 土默特右旗| 宜兰市| 富民县| 汝城县| 惠安县| 湘乡市| 肇州县| 射阳县| 福贡县|